Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 5NIH 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 10Stomach Neoplasms 8Prostatic Neoplasms 6Ovarian Neoplasms 5Neoplasms 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Ovarian Epithelial 4Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Lymphoma, Follicular 2Fallopian Tube Neoplasms 2COVID-19 2Breast Cancer Lymphedema 2Anxiety Disorders 2Adenoma 2Uveitis 1Uterine Cervical Dysplasia 1Stress, Psychological 1Stomatitis 1Skin Neoplasms 1Scleritis 1Renal Insufficiency, Chronic 1Radiation Injuries 1Pulmonary Disease, Chronic Obstructive 1Progression-Free Survival 1Ovarian, Fallopian, and Primary Peritoneal Cancer 1Operable Breast Cancer 1

Interventions

pembrolizumab 1lenvatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER_GOV × Adrenocortical Carcinoma × Clear all
NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting
30 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡